Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 100 | 0 | 70 | 0 |
| Gross Profit | N/A | 100 | N/A | 70 | N/A |
| Operating Expenses | 4,942 | 3,180 | 4,414 | 4,938 | 5,847 |
| Operating Income | -4,942 | -3,080 | -4,414 | -4,868 | -5,847 |
| Other Income | 66 | 126 | 165 | 209 | 161 |
| Pre-tax Income | -4,876 | -2,954 | -4,249 | -4,659 | -5,686 |
| Income Tax | -387 | N/A | N/A | N/A | -962 |
| Net Income Continuous | -4,489 | -2,954 | -4,249 | -4,659 | -4,724 |
| Net Income | $-4,489 | $-2,954 | $-4,249 | $-4,659 | $-4,724 |
| EPS Basic Total Ops | -0.50 | -0.33 | -0.49 | -0.54 | -0.55 |
| EPS Basic Continuous Ops | -0.50 | -0.33 | -0.49 | -0.54 | -0.55 |
| EPS Diluted Total Ops | -0.50 | -0.33 | -0.49 | -0.54 | -0.55 |
| EPS Diluted Continuous Ops | -0.50 | -0.33 | -0.49 | -0.54 | -0.55 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.33 | -0.49 | -0.54 | -0.55 |
| EBITDA(a) | $-4,940 | $-3,065 | $-4,384 | $-4,844 | $-5,845 |